Literature DB >> 2643809

Treatment guidelines for psychotropic drug use in pregnancy.

L S Cohen, V L Heller, J F Rosenbaum.   

Abstract

Despite the apparent risks of psychotropic drug exposure in pregnancy, many pregnant women receive psychotropics. The major concerns associated with the use of antipsychotics, antidepressants, benzodiazepines, and lithium carbonate in pregnancy are reviewed, with clinical approaches for assessing the relative risks and benefits of treatment of psychiatrically ill pregnant patients and for choosing and instituting therapy with these agents.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2643809     DOI: 10.1016/S0033-3182(89)72314-8

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


  7 in total

1.  Outcome of pregnancy following mothers' use of new SSRIs.

Authors:  W Potvin; M F Evans
Journal:  Can Fam Physician       Date:  1999-06       Impact factor: 3.275

Review 2.  Effects of antipsychotics on the unborn child: what is known and how should this influence prescribing?

Authors:  H B Pinkofsky
Journal:  Paediatr Drugs       Date:  2000 Mar-Apr       Impact factor: 3.022

Review 3.  The safety of newer antidepressants in pregnancy and breastfeeding.

Authors:  Salvatore Gentile
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 4.  [Gender differences in psychopharmacology].

Authors:  V Regitz-Zagrosek; C Schubert; S Krüger
Journal:  Internist (Berl)       Date:  2008-12       Impact factor: 0.743

Review 5.  Pharmacotherapy of insomnia: practice and prospects.

Authors:  J Dingemanse
Journal:  Pharm World Sci       Date:  1995-05-26

Review 6.  A clinical guide to antipsychotic drugs.

Authors:  J T Schwartz; A W Brotman
Journal:  Drugs       Date:  1992-12       Impact factor: 9.546

7.  Affect Expression and Self-Regulation Capacities of Infants Exposed in utero to Psychotropics.

Authors:  Pratibha N Reebye; Tammy W C Ng; Shaila Misri; Irena Stikarovska
Journal:  Front Psychiatry       Date:  2012-02-28       Impact factor: 4.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.